IP Library Granted Patent US 9,605,301
Granted Patent B2
US 9,605,301 · App. 14/456,321 · Granted Mar 28, 2017

Methods and solutions for inhibiting undesired cleaving of labels

Inventors: Jerzy Olejnik (Brookline, MA); Evan Guggenheim (Brookline, MA); Visalakshi Meyyappan (Ashland, MA)
Assignee: Intelligent Bio-Systems, Inc.
C12Q1/6806C12Q1/6825C12Q1/6869G06F19/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,605,301
App. No.
14/456,321
Granted
Mar 28, 2017
Kind
B2
Abstract

The invention provides methods and compositions, including, without limitation, algorithms, computer readable media, computer programs, apparatus, and systems for determining the identity of nucleic acids in nucleotide sequences using, for example, data obtained from sequencing by synthesis methods. The methods of the invention include correcting one or more phenomena that are encountered during nucleotide sequencing, such as using sequencing by synthesis methods. These phenomena include, without limitation, sequence lead, sequence lag, spectral crosstalk, and noise resulting from variations in illumination and/or filter responses.

Claims (25)

1. A method of incorporating labeled nucleotides into nucleic acid, comprising:

a) providing i) a reaction chamber comprising plurality of nucleic acid template molecules bound to a solid support, ii) a first solution comprising polymerase and a plurality of nucleotide analogues selected from the group consisting of dCTP, dTTP, dUTP, dATP and dGTP, wherein each nucleotide analogue comprises a unique label attached through a cleavable linker, and wherein each nucleotide analogue contains a removable chemical moiety capping the 3′-OH group, iii) a second solution comprising a cleaving agent, and iv) a cleaving agent scavenger;

b) introducing said first solution into said reaction chamber under conditions wherein a first nucleotide analogue is incorporated by said polymerase;

c) detecting the label of the incorporated nucleotide analogue;

d) introducing said second solution into said reaction chamber under conditions such that the chemical moiety of the incorporated nucleotide analogue capping the 3′-OH group is removed and said cleavable linker is cleaved by said cleaving agent; and

e) introducing said cleaving agent scavenger into said reaction chamber under conditions so as to scavenge said cleaving agent.

2. The method of claim 1 , wherein said cleavable linker comprises a disulfide bond.

3. The method of claim 1 , wherein said removable chemical moiety comprises an azido group.

4. The method of claim 1 , wherein said removable chemical moiety comprises an azidomethyl ether.

5. The method of claim 1 , wherein said cleaving agent is a phosphine.

6. The method of claim 5 , wherein said phosphine is Tris(2-carboxy-ethyl)phosphine.

7. The method of claim 1 , wherein said cleaving agent scavenger does not contain a nucleic acid base.

8. The method of claim 1 , wherein said cleaving agent scavenger is cystamine.

9. The method of claim 1 , wherein said cleaving agent scavenger comprises an azidomethyl group.

10. A method of incorporating labeled nucleotides into nucleic acid, comprising:

a) providing i) a reaction chamber comprising plurality of nucleic acid template molecules bound to a solid support, ii) a first solution comprising polymerase and a plurality of nucleotide analogues selected from the group consisting of dCTP, dTTP, dUTP, dATP and dGTP, wherein each nucleotide analogue comprises a unique label attached through a cleavable linker, and wherein each nucleotide analogue contains a removable chemical moiety capping the 3′-OH group, iii) a second solution comprising a cleaving agent, and iv) a cleaving agent scavenger, wherein said cleaving agent scavenger comprises a disulfide bond;

b) introducing said first solution into said reaction chamber under conditions wherein a first nucleotide analogue is incorporated by said polymerase;

c) detecting the label of the incorporated nucleotide analogue;

d) introducing said second solution into said reaction chamber under conditions such that the chemical moiety of the incorporated nucleotide analogue capping the 3′-OH group is removed and said cleavable linker is cleaved by said cleaving agent; and

e) introducing said cleaving agent scavenger into said reaction chamber under conditions so as to scavenge said cleaving agent.

11. The method of claim 10 , wherein said cleavable linker comprises a disulfide bond.

12. The method of claim 10 , wherein said cleaving agent is a phosphine.

13. The method of claim 12 , wherein said phosphine is Tris(2-carboxy-ethyl)phosphine.

14. The method of claim 10 , wherein said cleaving agent scavenger does not contain a nucleic acid base.

15. The method of claim 10 , wherein said cleaving agent scavenger is cystamine.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2023
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: ISOPLEXIS CORPORATION
Reel/Frame 063235/0942 →
PATENT PURCHASE AGREEMENT Recorded Jul 30, 2021
From: QIAGEN SCIENCES, LLC
To: ISOPLEXIS CORPORATION
Reel/Frame 057043/0629 →
SECURITY AGREEMENT Recorded May 28, 2021
From: ISOPLEXIS CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 056421/0929 →
MERGER Recorded Nov 8, 2018
From: QIAGEN WALTHAM, INC.
To: QIAGEN SCIENCES, LLC
Reel/Frame 047923/0815 →
CHANGE OF NAME Recorded May 17, 2018
From: INTELLIGENT BIO-SYSTEMS, INC.
To: QIAGEN WALTHAM, INC.
Reel/Frame 047132/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2016
From: OLEJNIK, JERZY; GUGGENHEIM, EVAN; MEYYAPPAN, VISALAKSHI
To: INTELLIGENT BIO-SYSTEMS, INC.
Reel/Frame 037874/0709 →
Continuity (3)
Continuation 12045925 · Mar 17, 2009
Provisional Application 61037845 · Mar 19, 2008
Related Publication 20150099647A1 · Apr 9, 2015